Abstract
The use of antibiotics during a disease outbreak presents a critical tradeoff between immediate treatment benefits to the individual and the long-term risk to the population. Typically, the extensive use of antibiotics has been thought to increase selective pressures, leading to resistance. This study explores scenarios where expanded antibiotic treatment can be advantageous for both individual and population health. We develop a mathematical framework to assess the impacts on outbreak dynamics of choosing to treat moderate infections not treated under current guidelines, focusing on cholera as a case study. We derive conditions under which treating moderate infections can sufficiently decrease transmission and reduce the total number of antibiotic doses administered. We identify two critical thresholds: the Outbreak Prevention Threshold (OPT), where expanded treatment reduces the reproductive number below 1 and halts transmission, and the Dose Utilization Threshold (DUT), where expanded treatment results in fewer total antibiotic doses used than under current guidelines. For cholera, we find that treating moderate infections can feasibly stop an outbreak when the untreated reproductive number is less than 1.424 and will result in fewer does used compared to current guidelines when the untreated reproductive number is less than 1.533. These findings demonstrate that conditions exist under which expanding treatment to include moderate infections can reduce disease spread and the selective pressure for antibiotic resistance. These findings extend to other pathogens and outbreak scenarios, suggesting potential targets for optimized treatment strategies that balance public health benefits and antibiotic stewardship.
Competing Interest Statement
CRL, DJAT, FRA, LTK acknowledge funding from the Centers for Disease Control and Prevention (CDC) TRANSMIT: Training Research Acumen in Students Modeling Infectious Threats (Grant #1U01CK000675). SMA, DJAT, LTK acknowledge funding from the CDC Centers for Forecasting and Outbreak Analytics (CFA) (Grant #1NU38FT000009-01-00). VMV acknowledges funding from Agency for Healthcare Research and Quality (AHRQ) (Grant #5K08HS026530-06). The authors thank Daniel Leung, Andrew Azman, and Iza Ciglenecki for helpful discussions about framing the research project.
Funding Statement
CRL, DJAT, FRA, LTK acknowledge funding from the Centers for Disease Control and Prevention (CDC) TRANSMIT: Training Research Acumen in Students Modeling Infectious Threats (Grant #1U01CK000675). SMA, DJAT, LTK acknowledge funding from the CDC Centers for Forecasting and Outbreak Analytics (CFA) (Grant #1NU38FT000009-01-00). VMV acknowledges funding from Agency for Healthcare Research and Quality (AHRQ) (Grant #5K08HS026530-06).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Statements and Declarations Competing interests The authors declare that they have no competing interests.
Data Availability
No data is produced in this study and all code produced is available online at: https://github.com/UT-IDDynamics/Cholera_Threshold.
